Unknown

Dataset Information

0

Long-term complications of glycogen storage disease type Ia in the canine model treated with gene replacement therapy.


ABSTRACT: BACKGROUND:Glycogen storage disease type Ia (GSD Ia) in dogs closely resembles human GSD Ia. Untreated patients with GSD Ia develop complications associated with glucose-6-phosphatase (G6Pase) deficiency. Survival of human patients on intensive nutritional management has improved; however, long-term complications persist including renal failure, nephrolithiasis, hepatocellular adenomas (HCA), and a high risk for hepatocellular carcinoma (HCC). Affected dogs fail to thrive with dietary therapy alone. Treatment with gene replacement therapy using adeno-associated viral vectors (AAV) expressing G6Pase has greatly prolonged life and prevented hypoglycemia in affected dogs. However, long-term complications have not been described to date. METHODS:Five GSD Ia-affected dogs treated with AAV-G6Pase were evaluated. Dogs were euthanized due to reaching humane endpoints related to liver and/or kidney involvement, at 4 to 8 years of life. Necropsies were performed and tissues were analyzed. RESULTS:Four dogs had liver tumors consistent with HCA and HCC. Three dogs developed renal failure, but all dogs exhibited progressive kidney disease histologically. Urolithiasis was detected in two dogs; uroliths were composed of calcium oxalate and calcium phosphate. One affected and one carrier dog had polycystic ovarian disease. Bone mineral density was not significantly affected. CONCLUSIONS:Here, we show that the canine GSD Ia model demonstrates similar long-term complications as GSD Ia patients in spite of gene replacement therapy. Further development of gene therapy is needed to develop a more effective treatment to prevent long-term complications of GSD Ia.

SUBMITTER: Brooks ED 

PROVIDER: S-EPMC6328337 | biostudies-literature | 2018 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Long-term complications of glycogen storage disease type Ia in the canine model treated with gene replacement therapy.

Brooks Elizabeth D ED   Landau Dustin J DJ   Everitt Jeffrey I JI   Brown Talmage T TT   Grady Kylie M KM   Waskowicz Lauren L   Bass Cameron R CR   D'Angelo John J   Asfaw Yohannes G YG   Williams Kyha K   Kishnani Priya S PS   Koeberl Dwight D DD  

Journal of inherited metabolic disease 20180724 6


<h4>Background</h4>Glycogen storage disease type Ia (GSD Ia) in dogs closely resembles human GSD Ia. Untreated patients with GSD Ia develop complications associated with glucose-6-phosphatase (G6Pase) deficiency. Survival of human patients on intensive nutritional management has improved; however, long-term complications persist including renal failure, nephrolithiasis, hepatocellular adenomas (HCA), and a high risk for hepatocellular carcinoma (HCC). Affected dogs fail to thrive with dietary th  ...[more]

Similar Datasets

| S-EPMC3764490 | biostudies-literature
| S-EPMC2938360 | biostudies-literature
| S-EPMC6954303 | biostudies-literature
| S-EPMC7003036 | biostudies-literature
| S-EPMC2889730 | biostudies-literature
| S-EPMC2683272 | biostudies-literature
| S-EPMC7014716 | biostudies-literature
| S-EPMC6483852 | biostudies-literature
| S-EPMC8621617 | biostudies-literature
| S-EPMC4752035 | biostudies-literature